Get the app!
Back to Trades
Other4

Emergent BioSolutions Inc.

EBS

Total Value
$105.7K

Company Information

Ticker Symbol
EBS
CIK
0001367644

Insider Information

Role
SVP, Products Business
Officer
Location
GAITHERSBURG, MD

Filing Details

Filing Date
Feb 10, 2026
Transaction Date
Feb 6, 2026
Accession Number
0001961994-26-000003
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 6, 2026Common Stock8,655$10.92Disposition$94.5K
Feb 6, 2026Common Stock1,022$10.92Tax Withholding$11.2K

Footnotes

  1. (F1)Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 2,884 shares of common stock, which is less than the 11,539 shares previously reported on March 02, 2023 and June 09, 2023.
  2. (F2)Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.